The Genomics of Neonatal Abstinence Syndrome
Significant variability has been observed in the development and severity of neonatal abstinence syndrome (NAS) among neonates exposed to prenatal opioids. Since maternal opioid dose does not appear to correlate directly with neonatal outcome, maternal, placental, and fetal genomic variants may play...
Saved in:
Main Authors: | F. Sessions Cole (Author), Daniel J. Wegner (Author), Jonathan M. Davis (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: The neurology and neurobiology of neonatal abstinence syndrome
by: Kelly J. Clemens, et al.
Published: (2023) -
Improving the Assessment of Neonatal Abstinence Syndrome (NAS)
by: Claire A. Chin Foo, et al.
Published: (2021) -
Neonatal Abstinence Syndrome: Twins Case Series
by: Rajesh Pandey, et al.
Published: (2017) -
Feeding Modalities and the Onset of the Neonatal Abstinence Syndrome
by: Anthony eLiu, et al.
Published: (2015) -
Neonatal Abstinence Syndrome Due to Opioid Abuse in Pregnancy
by: Banu Mutlu Ozyurt, et al.
Published: (2018)